开源证券维持天士力买入评级归母净利润扭亏为盈创新研发赋能向好发展

每日经济新闻04-16

开源证券04月16日发布研报称，维持天士力（600535.SH，最新价：15.04元）买入评级。评级理由主要包括：1）营收稳健增长，归母净利润扭亏；2）心脑血管、感冒发烧等领域营收增长稳健，肝病治疗产品受集采因素扰动；3）研发创新持续推进，中药、生物药、化药协同发展。风险提示：市场竞争加剧，产品研发进展不及预期，产品销售不及预期。文章来源：每日经济新闻原标题：开源证券维持天士力买入评级，归母净利润...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2427998892?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-16 13:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2427998892","market":"sh","top_or_hot":-1,"title":"开源证券维持天士力买入评级 归母净利润扭亏为盈 创新研发赋能向好发展","media":"每日经济新闻","content":"<div>\n<p>开源证券04月16日发布研报称，维持天士力（600535.SH，最新价：15.04元）买入评级。评级理由主要包括：1）营收稳健增长，归母净利润扭亏；2）心脑血管、感冒发烧等领域营收增长稳健，肝病治疗产品受集采因素扰动；3）研发创新持续推进，中药、生物药、化药协同发展。风险提示：市场竞争加剧，产品研发进展不及预期，产品销售不及预期。文章来源：每日经济新闻原标题：开源证券维持天士力买入评级，归母净利润...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161349068b2909af&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>开源证券维持天士力买入评级 归母净利润扭亏为盈 创新研发赋能向好发展</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n开源证券维持天士力买入评级 归母净利润扭亏为盈 创新研发赋能向好发展\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-16 13:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161349068b2909af&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>开源证券04月16日发布研报称，维持天士力（600535.SH，最新价：15.04元）买入评级。评级理由主要包括：1）营收稳健增长，归母净利润扭亏；2）心脑血管、感冒发烧等领域营收增长稳健，肝病治疗产品受集采因素扰动；3）研发创新持续推进，中药、生物药、化药协同发展。风险提示：市场竞争加剧，产品研发进展不及预期，产品销售不及预期。文章来源：每日经济新闻原标题：开源证券维持天士力买入评级，归母净利润...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161349068b2909af&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600535","symbol_name":"天士力","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161349068b2909af&s=b","article_id":"2427998892","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161349068b2909af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2427998892","pubTimestamp":1713246014,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"开源证券04月16日发布研报称，维持天士力（600535.SH，最新价：15.04元）买入评级。评级理由主要包括：1）营收稳健增长，归母净利润扭亏；2）心脑血管、感冒发烧等领域营收增长稳健，肝病治疗产品受集采因素扰动；3）研发创新持续推进，中药、生物药、化药协同发展。风险提示：市场竞争加剧，产品研发进展不及预期，产品销售不及预期。文章来源：每日经济新闻原标题：开源证券维持天士力买入评级，归母净利润扭亏为盈，创新研发赋能向好发展","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate","earning"],"viewcount":null,"language":"zh","relate_stocks":{"600535":"天士力"},"translate_title":"Kaiyuan Securities maintains Tasly's buy rating, net profit attributable to the parent turns losses into profits, innovative R&D empowers positive development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":0.9},"content_text":"开源证券04月16日发布研报称，维持天士力（600535.SH，最新价：15.04元）买入评级。评级理由主要包括：1）营收稳健增长，归母净利润扭亏；2）心脑血管、感冒发烧等领域营收增长稳健，肝病治疗产品受集采因素扰动；3）研发创新持续推进，中药、生物药、化药协同发展。风险提示：市场竞争加剧，产品研发进展不及预期，产品销售不及预期。文章来源：每日经济新闻原标题：开源证券维持天士力买入评级，归母净利润扭亏为盈，创新研发赋能向好发展","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2427998892"}

开源证券维持天士力买入评级 归母净利润扭亏为盈 创新研发赋能向好发展

精彩评论

开源证券维持天士力买入评级归母净利润扭亏为盈创新研发赋能向好发展